BDTX: blackdiamondtherapeutics.com Net earnings per share for the last 12 months

Symbol and logo of brand Black Diamond Therapeutics (BDTX)

Black Diamond (BDTX) faces an operational deficit and high R&D costs, where the current status equals -0.77. The trailing 12-month earnings per share demonstrate stable cash flows despite geopolitical barriers in biomaterial procurement. Meanwhile, independence from macro cycles transforms the development of targeted therapy into a resilient defensive asset for investors.

BDTX (Black Diamond) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/15/2026

Analytical breakdowns for Black Diamond

Basic company analysis:Black Diamond - BDTX
Manufactured products of Black Diamond Therapeutics, Inc.

To select high-quality assets, an investor must evaluate real business efficiency through the lens of per-share profit. This TTM earnings per share metric reflects annual net income divided by the number of securities, allowing for an assessment of Black Diamond (BDTX) profitability while accounting for the optimization of oncology research outsourcing costs and the retention of IP rights.

Who Black Diamond competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (Exelixis Corp)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|KYMR: Earnings per share for the last four quarters|IDYA (IDEAYA Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) enliventherapeutics.com|Earnings per share for the last twelve months ORIC Pharmaceuticals, Inc. (ORIC)|RLAY (Relay Therapeutics, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NRIX (Nurix Therapeutics Inc)|Net earnings per share for the trailing year Tyra Bio|Verastem Oncology - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Monte Rosa Therapeutics, Inc.|CGEM (Cullinan Therapeutics) - Net earnings per share for the last 12 months|IMRX: Earnings per share for the last four quarters|CCCC (c4therapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repare Rx RPTX|Net earnings per share (EPS TTM) PMVP|Karyopharm - Earnings per share for the last 12 months|Propanc Biopharma Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|aileronrx.com - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics Inc. - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics, Inc) - Net earnings per share (EPS TTM)